Judy M2 Posted May 4, 2021 Share Posted May 4, 2021 Someone just posted the article below on the LUNGevity FB EGFR Resisters Group page regarding a promising trial for a combo treatment after progression on Tagrisso. https://www.targetedonc.com/view/oleclumab-plus-osimertinib-show-early-activity-and-tolerability-egfr-mutant-nsclc Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.